Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQJW7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,230
Award facts
- Contract value 100% obligated
- $40,230.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,230.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. The delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, represents a firm fixed-price procurement with no set-aside designation. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value through December 31, 2036.
The PPV-G GEN V represents a broader $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense military healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors authorized to supply a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables on a firm fixed-price basis. The company's established performance across numerous delivery orders demonstrates its capability to meet the specialized pharmaceutical requirements of the federal military medical system, with this particular delivery order for Nexplanon contraceptive implants supporting recurring medical supply needs across the Defense Department's healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQJW7?
SPE2DR26FQJW7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQJW7 worth?
The government has obligated $40,230 on SPE2DR26FQJW7.
Is contract SPE2DR26FQJW7 an order under another contract?
Yes. SPE2DR26FQJW7 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJW7 competed?
The extent of competition for SPE2DR26FQJW7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award